-
1
-
-
84876334028
-
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
-
C.Gudiol, M.Bodro, A.Simonetti,. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19:474–479.
-
(2013)
Clin Microbiol Infect
, vol.19
, pp. 474-479
-
-
Gudiol, C.1
Bodro, M.2
Simonetti, A.3
-
2
-
-
84859962764
-
Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies
-
P.Cornejo-Juárez, C.Pérez-Jiménez, J.Silva-Sánchez,. Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies. PLoS One. 2012;7:e35780.
-
(2012)
PLoS One
, vol.7
, pp. e35780
-
-
Cornejo-Juárez, P.1
Pérez-Jiménez, C.2
Silva-Sánchez, J.3
-
3
-
-
84896694664
-
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact
-
E.M.Trecarichi, M.Tumbarello Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer:current epidemiology and clinical impact. Curr Opin Infect Dis. 2014;27:200–210.
-
(2014)
Curr Opin Infect Dis
, vol.27
, pp. 200-210
-
-
Trecarichi, E.M.1
Tumbarello, M.2
-
4
-
-
84879180123
-
Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance
-
E.Montassier, E.Batard, T.Gastinne,. Recent changes in bacteremia in patients with cancer:a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841–850.
-
(2013)
Eur J Clin Microbiol Infect Dis
, vol.32
, pp. 841-850
-
-
Montassier, E.1
Batard, E.2
Gastinne, T.3
-
5
-
-
84902769829
-
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies
-
L.Pagano, M.Caira, E.M.Trecarichi,. Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerging Infect Dis. 2014;20:1235–1236.
-
(2014)
Emerging Infect Dis
, vol.20
, pp. 1235-1236
-
-
Pagano, L.1
Caira, M.2
Trecarichi, E.M.3
-
6
-
-
79951816939
-
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america
-
A.G.Freifeld, E.J.Bow, K.A.Sepkowitz,. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer:2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52:e56–e93.
-
(2011)
Clin Infect Dis
, vol.52
, pp. e56-e93
-
-
Freifeld, A.G.1
Bow, E.J.2
Sepkowitz, K.A.3
-
7
-
-
84928546728
-
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
-
E.M.Trecarichi, L.Pagano, A.Candoni,. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies:an Italian multicentre prospective survey. Clin Microbiol Infect. 2015;21:337–343.
-
(2015)
Clin Microbiol Infect
, vol.21
, pp. 337-343
-
-
Trecarichi, E.M.1
Pagano, L.2
Candoni, A.3
-
8
-
-
24344471724
-
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
-
G.Bucaneve, A.Micozzi, F.Menichetti,. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353:977–987.
-
(2005)
N Engl J Med
, vol.353
, pp. 977-987
-
-
Bucaneve, G.1
Micozzi, A.2
Menichetti, F.3
-
9
-
-
77953685297
-
Escherichia coli resistance to quinolones at a comprehensive cancer center
-
C.N.Mihu, P.R.Rhomberg, R.N.Jones,. Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis. 2010;67:266–269.
-
(2010)
Diagn Microbiol Infect Dis
, vol.67
, pp. 266-269
-
-
Mihu, C.N.1
Rhomberg, P.R.2
Jones, R.N.3
-
10
-
-
77950261972
-
Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
-
C.Gudiol, L.Calatayud, C.Garcia-Vidal,. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients:clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother. 2010;65:333–341.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 333-341
-
-
Gudiol, C.1
Calatayud, L.2
Garcia-Vidal, C.3
-
11
-
-
84857375975
-
Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy
-
C.-I.Kang, D.R.Chung, K.S.Ko,. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol. 2012;91:115–121.
-
(2012)
Ann Hematol
, vol.91
, pp. 115-121
-
-
Kang, C.-I.1
Chung, D.R.2
Ko, K.S.3
-
12
-
-
84877065762
-
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome
-
S.-H.Kim, J.-C.Kwon, S.-M.Choi,. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever:factors associated with extended-spectrum β-lactamase production and its impact on outcome. Ann Hematol. 2013;92:533–541.
-
(2013)
Ann Hematol
, vol.92
, pp. 533-541
-
-
Kim, S.-H.1
Kwon, J.-C.2
Choi, S.-M.3
-
13
-
-
34250188146
-
Epidemiology of bacteremia and factors associated with multi-drug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients
-
A.L.Oliveira, M.de Souza, V.M.H.Carvalho-Dias,. Epidemiology of bacteremia and factors associated with multi-drug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2007;39:775–781.
-
(2007)
Bone Marrow Transplant
, vol.39
, pp. 775-781
-
-
Oliveira, A.L.1
de Souza, M.2
Carvalho-Dias, V.M.H.3
-
14
-
-
84885428877
-
Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer
-
Y.E.Ha, C.-I.Kang, M.K.Cha,. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer. Int J Antimicrob Agents. 2013;42:403–409.
-
(2013)
Int J Antimicrob Agents
, vol.42
, pp. 403-409
-
-
Ha, Y.E.1
Kang, C.-I.2
Cha, M.K.3
-
15
-
-
84876706549
-
Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases
-
G.Metan, H.Demiraslan, L.G.Kaynar,. Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia:a retrospective analysis of 154 cases. Braz J Infect Dis. 2013;17:143–149.
-
(2013)
Braz J Infect Dis
, vol.17
, pp. 143-149
-
-
Metan, G.1
Demiraslan, H.2
Kaynar, L.G.3
-
16
-
-
84983565508
-
The changing epidemiology of blood stream infections and resistance in haematopoietic stem cell transplantation recipients
-
M.Yemişen, İ.İ.Balkan, A.Salihoğlu,. The changing epidemiology of blood stream infections and resistance in haematopoietic stem cell transplantation recipients. Turk J Haematol. 2015. [Epub ahead of print]. doi:10.4274/tjh.2014.0378.
-
(2015)
Turk J Haematol
-
-
Yemişen, M.1
Balkan, İ.İ.2
Salihoğlu, A.3
-
17
-
-
22144433025
-
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection
-
E.P.Hyle, A.D.Lipworth, T.E.Zaoutis,. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae:variability by site of infection. Arch Intern Med. 2005;165:1375–1380.
-
(2005)
Arch Intern Med
, vol.165
, pp. 1375-1380
-
-
Hyle, E.P.1
Lipworth, A.D.2
Zaoutis, T.E.3
-
18
-
-
84863342359
-
Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States
-
Y.S.Park, J.M.Adams-Haduch, K.A.Shutt,. Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States. Antimicrob Agents Chemother. 2012;56:1870–1876.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 1870-1876
-
-
Park, Y.S.1
Adams-Haduch, J.M.2
Shutt, K.A.3
-
19
-
-
84893488813
-
Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine United States census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups
-
M.Castanheira, S.E.Farrell, K.M.Krause,. Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine United States census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups. Antimicrob Agents Chemother. 2013;58:833–838.
-
(2013)
Antimicrob Agents Chemother
, vol.58
, pp. 833-838
-
-
Castanheira, M.1
Farrell, S.E.2
Krause, K.M.3
-
20
-
-
84873021014
-
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters
-
N.-Y.Lee, C.-C.Lee, W.-H.Huang,. Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae:MIC matters. Clin Infect Dis. 2013;56:488–495.
-
(2013)
Clin Infect Dis
, vol.56
, pp. 488-495
-
-
Lee, N.-Y.1
Lee, C.-C.2
Huang, W.-H.3
-
21
-
-
84928879624
-
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia
-
P.D.Tamma, J.H.Han, C.Rock,. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Clin Infect Dis. 2015;60:1319–1325.
-
(2015)
Clin Infect Dis
, vol.60
, pp. 1319-1325
-
-
Tamma, P.D.1
Han, J.H.2
Rock, C.3
-
22
-
-
0035189967
-
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae
-
K.S.Thomson, E.S.Moland Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2001;45:3548–3554.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 3548-3554
-
-
Thomson, K.S.1
Moland, E.S.2
-
23
-
-
59649115459
-
AmpC beta-lactamases
-
G.A.Jacoby AmpC beta-lactamases. Clin Microbiol Rev. 2009;22:161–182.
-
(2009)
Clin Microbiol Rev
, vol.22
, pp. 161-182
-
-
Jacoby, G.A.1
-
24
-
-
0025938759
-
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy
-
J.W.Chow, M.J.Fine, D.M.Shlaes,. Enterobacter bacteremia:clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991;115:585–590.
-
(1991)
Ann Intern Med
, vol.115
, pp. 585-590
-
-
Chow, J.W.1
Fine, M.J.2
Shlaes, D.M.3
-
25
-
-
40549134482
-
Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use
-
S.-H.Choi, J.E.Lee, S.J.Park,. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase:implications for antibiotic use. Antimicrob Agents Chemother. 2008;52:995–1000.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 995-1000
-
-
Choi, S.-H.1
Lee, J.E.2
Park, S.J.3
-
26
-
-
84962514723
-
Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies
-
Ö.Kara, P.Zarakolu, S.Aşçioğlu,. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies. Infect Dis (Lond). 2015;47:686–693.
-
(2015)
Infect Dis (Lond)
, vol.47
, pp. 686-693
-
-
Kara, Ö.1
Zarakolu, P.2
Aşçioğlu, S.3
-
27
-
-
12344334529
-
Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase
-
C.-I.Kang, H.Pai, S.-H.Kim,. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase. J Antimicrob Chemother. 2004;54:1130–1133.
-
(2004)
J Antimicrob Chemother
, vol.54
, pp. 1130-1133
-
-
Kang, C.-I.1
Pai, H.2
Kim, S.-H.3
-
28
-
-
84883238476
-
The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae
-
P.D.Tamma, S.C.T.Girdwood, R.Gopaul,. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57:781–788.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 781-788
-
-
Tamma, P.D.1
Girdwood, S.C.T.2
Gopaul, R.3
-
29
-
-
84954537407
-
Cefepime therapy for monomicrobial enterobacter cloacae bacteremia: unfavorable outcomes in patients infected by cefepime-susceptible dose-dependent isolates
-
N.-Y.Lee, C.-C.Lee, C.-W.Li,. Cefepime therapy for monomicrobial enterobacter cloacae bacteremia:unfavorable outcomes in patients infected by cefepime-susceptible dose-dependent isolates. Antimicrob Agents Chemother. 2015;59:7558–7563.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 7558-7563
-
-
Lee, N.-Y.1
Lee, C.-C.2
Li, C.-W.3
-
30
-
-
47249127343
-
Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia
-
M.Marcos, A.Iñurrieta, A.Soriano,. Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. J Antimicrob Chemother. 2008;62:397–403.
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 397-403
-
-
Marcos, M.1
Iñurrieta, A.2
Soriano, A.3
-
31
-
-
84959909713
-
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis
-
P.N.A.Harris, J.Y.Wei, A.W.Shen,. Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species:a systematic review with meta-analysis. J Antimicrob Chemother. 2016;71:296–306.
-
(2016)
J Antimicrob Chemother
, vol.71
, pp. 296-306
-
-
Harris, P.N.A.1
Wei, J.Y.2
Shen, A.W.3
-
32
-
-
84898867259
-
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies
-
M.J.Satlin, S.G.Jenkins, T.J.Walsh The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58:1274–1283.
-
(2014)
Clin Infect Dis
, vol.58
, pp. 1274-1283
-
-
Satlin, M.J.1
Jenkins, S.G.2
Walsh, T.J.3
-
33
-
-
84922330557
-
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy
-
C.Girmenia, G.M.Rossolini, A.Piciocchi,. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients:a nationwide retrospective survey from Italy. Bone Marrow Transplant. 2015;50:282–288.
-
(2015)
Bone Marrow Transplant
, vol.50
, pp. 282-288
-
-
Girmenia, C.1
Rossolini, G.M.2
Piciocchi, A.3
-
34
-
-
84930486688
-
Global spread of carbapenemase-producing Enterobacteriaceae
-
P.Nordmann, T.Naas, L.Poirel Global spread of carbapenemase-producing Enterobacteriaceae. Emerging Infect Dis. 2011;17:1791–1798.
-
(2011)
Emerging Infect Dis
, vol.17
, pp. 1791-1798
-
-
Nordmann, P.1
Naas, T.2
Poirel, L.3
-
35
-
-
84942240891
-
Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance
-
J.D.D.Pitout, P.Nordmann, L.Poirel Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59:5873–5884.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 5873-5884
-
-
Pitout, J.D.D.1
Nordmann, P.2
Poirel, L.3
-
36
-
-
67651085441
-
Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns
-
K.Hussein, H.Sprecher, T.Mashiach,. Carbapenem resistance among Klebsiella pneumoniae isolates:risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30:666–671.
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 666-671
-
-
Hussein, K.1
Sprecher, H.2
Mashiach, T.3
-
37
-
-
84875386814
-
Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae
-
K.Hussein, A.Raz-Pasteur, R.Finkelstein,. Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83:307–313.
-
(2013)
J Hosp Infect
, vol.83
, pp. 307-313
-
-
Hussein, K.1
Raz-Pasteur, A.2
Finkelstein, R.3
-
38
-
-
73449096797
-
Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae
-
L.B.Gasink, P.H.Edelstein, E.Lautenbach,. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180–1185.
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 1180-1185
-
-
Gasink, L.B.1
Edelstein, P.H.2
Lautenbach, E.3
-
39
-
-
84982831231
-
-
M.J.Satlin, N.Cohen, K.C.Ma,. Prevalence, risk factors, and outcomes of bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies [abstract #434]. Poster presented at:IDWeek; 2014 Oct 9; Philadelphia, PA.
-
-
-
Satlin, M.J.1
Cohen, N.2
Ma, K.C.3
-
40
-
-
84921766986
-
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients
-
M.P.Freire, L.C.Pierrotti, H.H.C.Filho,. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients. Eur J Clin Microbiol Infect Dis. 2015;34:277–286.
-
(2015)
Eur J Clin Microbiol Infect Dis
, vol.34
, pp. 277-286
-
-
Freire, M.P.1
Pierrotti, L.C.2
Filho, H.H.C.3
-
41
-
-
84904554359
-
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
-
I.I.Balkan, G.Aygün, S.Aydın,. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae:treatment and survival. Int J Infect Dis. 2014;26:51–56.
-
(2014)
Int J Infect Dis
, vol.26
, pp. 51-56
-
-
Balkan, I.I.1
Aygün, G.2
Aydın, S.3
-
42
-
-
84898606478
-
In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy
-
K.Phe, Y.Lee, P.M.McDaneld,. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy. Antimicrob Agents Chemother. 2014;58:2740–2746.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 2740-2746
-
-
Phe, K.1
Lee, Y.2
McDaneld, P.M.3
-
43
-
-
0015786342
-
Advances in the management of Pseudomonas aeruginosa infections in cancer patients
-
G.P.Bodey, V.Rodriguez Advances in the management of Pseudomonas aeruginosa infections in cancer patients. Eur J Cancer. 1973;9:435–441.
-
(1973)
Eur J Cancer
, vol.9
, pp. 435-441
-
-
Bodey, G.P.1
Rodriguez, V.2
-
44
-
-
84871618339
-
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
-
A.Capone, M.Giannella, D.Fortini,. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19:E23–E30.
-
(2013)
Clin Microbiol Infect
, vol.19
, pp. E23-E30
-
-
Capone, A.1
Giannella, M.2
Fortini, D.3
-
45
-
-
80051692552
-
Efficacy and safety of tigecycline: a systematic review and meta-analysis
-
D.Yahav, A.Lador, M.Paul,. Efficacy and safety of tigecycline:a systematic review and meta-analysis. J Antimicrob Chemother. 2011;66:1963–1971.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 1963-1971
-
-
Yahav, D.1
Lador, A.2
Paul, M.3
-
47
-
-
0022219276
-
Pseudomonas bacteremia. Retrospective analysis of 410 episodes
-
G.P.Bodey, L.Jadeja, L.Elting Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med. 1985;145:1621–1629.
-
(1985)
Arch Intern Med
, vol.145
, pp. 1621-1629
-
-
Bodey, G.P.1
Jadeja, L.2
Elting, L.3
-
48
-
-
84872180720
-
Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County
-
P.Marquez, D.Terashita, D.Dassey,. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol. 2013;34:144–150.
-
(2013)
Infect Control Hosp Epidemiol
, vol.34
, pp. 144-150
-
-
Marquez, P.1
Terashita, D.2
Dassey, D.3
-
49
-
-
84871635409
-
Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998–2010
-
G.V.Sanchez, R.N.Master, R.B.Clark,. Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998–2010. Emerging Infect Dis. 2013;19:133–136.
-
(2013)
Emerging Infect Dis
, vol.19
, pp. 133-136
-
-
Sanchez, G.V.1
Master, R.N.2
Clark, R.B.3
-
50
-
-
68749111844
-
A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function
-
W.M.Sweileh A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Fundam Clin Pharmacol. 2009;23:515–520.
-
(2009)
Fundam Clin Pharmacol
, vol.23
, pp. 515-520
-
-
Sweileh, W.M.1
-
51
-
-
84905985310
-
Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients
-
E.Van Maarseveen, M.-C.van Buul-Gast, R.Abdoellakhan,. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients. J Antimicrob Chemother. 2014;69:2581–2583.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 2581-2583
-
-
Van Maarseveen, E.1
van Buul-Gast, M.-C.2
Abdoellakhan, R.3
-
52
-
-
84896940320
-
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems
-
G.L.Daikos, S.Tsaousi, L.S.Tzouvelekis,. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections:lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58:2322–2328.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 2322-2328
-
-
Daikos, G.L.1
Tsaousi, S.2
Tzouvelekis, L.S.3
-
53
-
-
84858627056
-
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens
-
Z.A.Qureshi, D.L.Paterson, B.A.Potoski,. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae:superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56:2108–2113.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 2108-2113
-
-
Qureshi, Z.A.1
Paterson, D.L.2
Potoski, B.A.3
-
54
-
-
84866072596
-
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy
-
M.Tumbarello, P.Viale, C.Viscoli,. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae:importance of combination therapy. Clin Infect Dis. 2012;55:943–950.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 943-950
-
-
Tumbarello, M.1
Viale, P.2
Viscoli, C.3
-
55
-
-
84943751309
-
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study–authors’ response
-
M.Tumbarello, P.Viale, M.Bassetti,. Infections caused by KPC-producing Klebsiella pneumoniae:differences in therapy and mortality in a multicentre study–authors’ response. J Antimicrob Chemother. 2015;70:2922.
-
(2015)
J Antimicrob Chemother
, vol.70
, pp. 2922
-
-
Tumbarello, M.1
Viale, P.2
Bassetti, M.3
-
56
-
-
84929587395
-
Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains
-
M.Castanheira, J.C.Mills, S.E.Costello,. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains. Antimicrob Agents Chemother. 2015;59:3509–3517.
-
(2015)
Antimicrob Agents Chemother
, vol.59
, pp. 3509-3517
-
-
Castanheira, M.1
Mills, J.C.2
Costello, S.E.3
-
57
-
-
84940449628
-
Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections
-
J.L.Liscio, M.V.Mahoney, E.B.Hirsch Ceftolozane/tazobactam and ceftazidime/avibactam:two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections. Int J Antimicrob Agents. 2015;46:266–271.
-
(2015)
Int J Antimicrob Agents
, vol.46
, pp. 266-271
-
-
Liscio, J.L.1
Mahoney, M.V.2
Hirsch, E.B.3
-
58
-
-
0015800331
-
Pseudomonas septicemia: incidence, epidemiology, prevention and therapy in patients with advanced cancer
-
S.C.Schimpff, W.H.Greene, V.M.Young,. Pseudomonas septicemia:incidence, epidemiology, prevention and therapy in patients with advanced cancer. Eur J Cancer. 1973;9:449–455.
-
(1973)
Eur J Cancer
, vol.9
, pp. 449-455
-
-
Schimpff, S.C.1
Greene, W.H.2
Young, V.M.3
-
60
-
-
0036498656
-
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?
-
D.M.Livermore Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:our worst nightmare? Clin Infect Dis. 2002;34:634–640.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 634-640
-
-
Livermore, D.M.1
-
61
-
-
0034723745
-
Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes
-
I.Chatzinikolaou, D.Abi-Said, G.P.Bodey,. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer:retrospective analysis of 245 episodes. Arch Intern Med. 2000;160:501–509.
-
(2000)
Arch Intern Med
, vol.160
, pp. 501-509
-
-
Chatzinikolaou, I.1
Abi-Said, D.2
Bodey, G.P.3
-
62
-
-
0033059706
-
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents
-
Y.Carmeli, N.Troillet, G.M.Eliopoulos,. Emergence of antibiotic-resistant Pseudomonas aeruginosa:comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379–1382.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 1379-1382
-
-
Carmeli, Y.1
Troillet, N.2
Eliopoulos, G.M.3
-
63
-
-
0028274211
-
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group
-
M.P.Fink, D.R.Snydman, M.S.Niederman,. Treatment of severe pneumonia in hospitalized patients:results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother. 1994;38:547–557.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 547-557
-
-
Fink, M.P.1
Snydman, D.R.2
Niederman, M.S.3
-
64
-
-
10744230588
-
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study
-
G.Zanetti, F.Bally, G.Greub,. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients:a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother. 2003;47:3442–3447.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 3442-3447
-
-
Zanetti, G.1
Bally, F.2
Greub, G.3
-
65
-
-
84455192457
-
Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa
-
G.L.Drusano, R.A.Bonomo, N.Bahniuk,. Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2012;56:231–242.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 231-242
-
-
Drusano, G.L.1
Bonomo, R.A.2
Bahniuk, N.3
-
66
-
-
77952607034
-
The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression
-
A.Louie, C.Grasso, N.Bahniuk,. The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression. Antimicrob Agents Chemother. 2010;54:2646–2654.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2646-2654
-
-
Louie, A.1
Grasso, C.2
Bahniuk, N.3
-
67
-
-
77952650628
-
Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance
-
A.Louie, A.Bied, C.Fregeau,. Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance. Antimicrob Agents Chemother. 2010;54:2638–2645.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2638-2645
-
-
Louie, A.1
Bied, A.2
Fregeau, C.3
-
68
-
-
33846442436
-
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy
-
T.P.Lodise, B.Lomaestro, G.L.Drusano Piperacillin-tazobactam for Pseudomonas aeruginosa infection:clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007;44:357–363.
-
(2007)
Clin Infect Dis
, vol.44
, pp. 357-363
-
-
Lodise, T.P.1
Lomaestro, B.2
Drusano, G.L.3
-
69
-
-
84879017246
-
Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections
-
K.A.Bauer, J.E.West, J.M.O’Brien,. Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrob Agents Chemother. 2013;57:2907–2912.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 2907-2912
-
-
Bauer, K.A.1
West, J.E.2
O’Brien, J.M.3
-
70
-
-
84887449664
-
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011–2012)
-
D.J.Farrell, R.K.Flamm, H.S.Sader,. Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011–2012). Antimicrob Agents Chemother. 2013;57:6305–6310.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 6305-6310
-
-
Farrell, D.J.1
Flamm, R.K.2
Sader, H.S.3
-
71
-
-
84934963355
-
Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia
-
H.S.Sader, M.Castanheira, R.K.Flamm,. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia. Int J Antimicrob Agents. 2015;46:53–59.
-
(2015)
Int J Antimicrob Agents
, vol.46
, pp. 53-59
-
-
Sader, H.S.1
Castanheira, M.2
Flamm, R.K.3
-
72
-
-
47949089607
-
Acinetobacter baumannii: emergence of a successful pathogen
-
A.Y.Peleg, H.Seifert, D.L.Paterson Acinetobacter baumannii:emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–582.
-
(2008)
Clin Microbiol Rev
, vol.21
, pp. 538-582
-
-
Peleg, A.Y.1
Seifert, H.2
Paterson, D.L.3
-
73
-
-
84908506410
-
Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study
-
S.K.Seo, K.Xiao, Y.-T.Huang,. Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients:a 12-year single institution study. J Infect. 2014;69:341–351.
-
(2014)
J Infect
, vol.69
, pp. 341-351
-
-
Seo, S.K.1
Xiao, K.2
Huang, Y.-T.3
-
74
-
-
33747625237
-
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
-
R.A.Bonomo, D.Szabo Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43:S49–S56.
-
(2006)
Clin Infect Dis
, vol.43
, pp. S49-S56
-
-
Bonomo, R.A.1
Szabo, D.2
-
75
-
-
84932115203
-
Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options
-
M.Castanheira, R.E.Mendes, R.N.Jones Update on Acinetobacter species:mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. Clin Infect Dis. 2014;59:S367–S373.
-
(2014)
Clin Infect Dis
, vol.59
, pp. S367-S373
-
-
Castanheira, M.1
Mendes, R.E.2
Jones, R.N.3
-
77
-
-
80053448027
-
Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality
-
M.Turkoglu, E.Mirza, O.G.Tunçcan,. Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit:risk factors and impact on mortality. J Crit Care. 2011;26:460–467.
-
(2011)
J Crit Care
, vol.26
, pp. 460-467
-
-
Turkoglu, M.1
Mirza, E.2
Tunçcan, O.G.3
-
78
-
-
84862902944
-
Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy
-
Y.J.Kim, S.I.Kim, K.-W.Hong,. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia:impact of appropriate antimicrobial therapy. J Korean Med Sci. 2012;27:471–475.
-
(2012)
J Korean Med Sci
, vol.27
, pp. 471-475
-
-
Kim, Y.J.1
Kim, S.I.2
Hong, K.-W.3
-
79
-
-
84898007596
-
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
-
T.Khawcharoenporn, N.Pruetpongpun, P.Tiamsak,. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia. Int J Antimicrob Agents. 2014;43:378–382.
-
(2014)
Int J Antimicrob Agents
, vol.43
, pp. 378-382
-
-
Khawcharoenporn, T.1
Pruetpongpun, N.2
Tiamsak, P.3
-
80
-
-
84928887610
-
A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections
-
D.J.Ritchie, A.Garavaglia-Wilson A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. Clin Infect Dis. 2014;59:S374–S380.
-
(2014)
Clin Infect Dis
, vol.59
, pp. S374-S380
-
-
Ritchie, D.J.1
Garavaglia-Wilson, A.2
-
81
-
-
84949667186
-
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
-
Y.-T.Chang, C.-Y.Lin, Y.-H.Chen,. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893.
-
(2015)
Front Microbiol
, vol.6
, pp. 893
-
-
Chang, Y.-T.1
Lin, C.-Y.2
Chen, Y.-H.3
-
82
-
-
84855650410
-
Stenotrophomonas maltophilia: an emerging global opportunistic pathogen
-
J.S.Brooke Stenotrophomonas maltophilia:an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25:2–41.
-
(2012)
Clin Microbiol Rev
, vol.25
, pp. 2-41
-
-
Brooke, J.S.1
-
83
-
-
84958155803
-
Prevalence of resistant Gram-Negative Bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation: a single center retrospective cohort study
-
L.Wang, Y.Wang, X.Fan,. Prevalence of resistant Gram-Negative Bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation:a single center retrospective cohort study. Medicine (Baltimore). 2015;94:e1931.
-
(2015)
Medicine (Baltimore)
, vol.94
, pp. e1931
-
-
Wang, L.1
Wang, Y.2
Fan, X.3
-
84
-
-
80054083841
-
Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients
-
J.Cairo, R.Hachem, G.Rangaraj,. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect. 2011;17:1711–1716.
-
(2011)
Clin Microbiol Infect
, vol.17
, pp. 1711-1716
-
-
Cairo, J.1
Hachem, R.2
Rangaraj, G.3
-
85
-
-
16644397823
-
Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia
-
C.-H.Lai, C.-Y.Chi, H.-P.Chen,. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004;37:350–358.
-
(2004)
J Microbiol Immunol Infect
, vol.37
, pp. 350-358
-
-
Lai, C.-H.1
Chi, C.-Y.2
Chen, H.-P.3
-
86
-
-
33746606840
-
Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital
-
G.Metan, M.Hayran, G.Hascelik,. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis. 2006;38:527–531.
-
(2006)
Scand J Infect Dis
, vol.38
, pp. 527-531
-
-
Metan, G.1
Hayran, M.2
Hascelik, G.3
-
87
-
-
0038071628
-
Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study
-
A.Apisarnthanarak, J.L.Mayfield, T.Garison,. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients:a case-control study. Infect Control Hosp Epidemiol. 2003;24:269–274.
-
(2003)
Infect Control Hosp Epidemiol
, vol.24
, pp. 269-274
-
-
Apisarnthanarak, A.1
Mayfield, J.L.2
Garison, T.3
-
88
-
-
84887594809
-
Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients
-
H.Demiraslan, M.Sevim, Ç.Pala,. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol. 2013;97:414–420.
-
(2013)
Int J Hematol
, vol.97
, pp. 414-420
-
-
Demiraslan, H.1
Sevim, M.2
Pala, Ç.3
-
89
-
-
0034457193
-
Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies
-
A.Micozzi, M.Venditti, M.Monaco,. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000;31:705–711.
-
(2000)
Clin Infect Dis
, vol.31
, pp. 705-711
-
-
Micozzi, A.1
Venditti, M.2
Monaco, M.3
-
90
-
-
84928658419
-
Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
-
S.-Y.Cho, D.-G.Lee, S.-M.Choi,. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies:a retrospective study and in vitro activities of antimicrobial combinations. BMC Infect Dis. 2015;15:69.
-
(2015)
BMC Infect Dis
, vol.15
, pp. 69
-
-
Cho, S.-Y.1
Lee, D.-G.2
Choi, S.-M.3
-
91
-
-
77952597308
-
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections
-
D.J.Farrell, H.S.Sader, R.N.Jones Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections. Antimicrob Agents Chemother. 2010;54:2735–2737.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 2735-2737
-
-
Farrell, D.J.1
Sader, H.S.2
Jones, R.N.3
-
92
-
-
84891499399
-
Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections
-
Y.L.Wang, M.R.Scipione, Y.Dubrovskaya,. Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother. 2014;58:176–182.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 176-182
-
-
Wang, Y.L.1
Scipione, M.R.2
Dubrovskaya, Y.3
-
93
-
-
84891530851
-
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?
-
S.Y.Cho, C.-I.Kang, J.Kim,. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother. 2014;58:581–583.
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 581-583
-
-
Cho, S.Y.1
Kang, C.-I.2
Kim, J.3
-
94
-
-
84897997775
-
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY antimicrobial surveillance program, 2009-2012
-
H.S.Sader, D.J.Farrell, R.K.Flamm,. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals:results from the SENTRY antimicrobial surveillance program, 2009-2012. Int J Antimicrob Agents. 2014;43:328–334.
-
(2014)
Int J Antimicrob Agents
, vol.43
, pp. 328-334
-
-
Sader, H.S.1
Farrell, D.J.2
Flamm, R.K.3
-
95
-
-
84962069288
-
Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections
-
E.Hand, H.Davis, T.Kim,. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. J Antimicrob Chemother. 2016;71:1071–1075.
-
(2016)
J Antimicrob Chemother
, vol.71
, pp. 1071-1075
-
-
Hand, E.1
Davis, H.2
Kim, T.3
-
96
-
-
84925230536
-
Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria
-
M.Ruhnke, R.Arnold, P.Gastmeier Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol. 2014;15:e606–e619.
-
(2014)
Lancet Oncol
, vol.15
, pp. e606-e619
-
-
Ruhnke, M.1
Arnold, R.2
Gastmeier, P.3
-
97
-
-
84941073950
-
The prevention and management of infections due to multidrug resistant organisms in haematology patients
-
J.A.Trubiano, L.J.Worth, K.A.Thursky,. The prevention and management of infections due to multidrug resistant organisms in haematology patients. Br J Clin Pharmacol. 2015;79:195–207.
-
(2015)
Br J Clin Pharmacol
, vol.79
, pp. 195-207
-
-
Trubiano, J.A.1
Worth, L.J.2
Thursky, K.A.3
-
98
-
-
84890161363
-
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
-
E.Tacconelli, M.A.Cataldo, S.J.Dancer,. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1–55.
-
(2014)
Clin Microbiol Infect
, vol.20
, pp. 1-55
-
-
Tacconelli, E.1
Cataldo, M.A.2
Dancer, S.J.3
-
99
-
-
67649717007
-
Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae
-
S.Kochar, T.Sheard, R.Sharma,. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2009;30:447–452.
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, pp. 447-452
-
-
Kochar, S.1
Sheard, T.2
Sharma, R.3
-
100
-
-
77952163360
-
Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection
-
D.Ben-David, Y.Maor, N.Keller,. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol. 2010;31:620–626.
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, pp. 620-626
-
-
Ben-David, D.1
Maor, Y.2
Keller, N.3
-
101
-
-
84888434099
-
Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients
-
Y.Fukuta, R.R.Muder, M.E.Agha,. Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. Am J Infect Control. 2013;41:1249–1252.
-
(2013)
Am J Infect Control
, vol.41
, pp. 1249-1252
-
-
Fukuta, Y.1
Muder, R.R.2
Agha, M.E.3
-
102
-
-
84889781345
-
The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients
-
I.C.Gyssens, W.V.Kern, D.M.Livermore ECIL-4, A Joint Venture of EBMT, EORTC, ICHS and ESGICH of ESCMID. The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients. Haematologica. 2013;98:1821–1825.
-
(2013)
Haematologica
, vol.98
, pp. 1821-1825
-
-
Gyssens, I.C.1
Kern, W.V.2
Livermore, D.M.3
-
103
-
-
84888416637
-
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial
-
I.Oren, H.Sprecher, R.Finkelstein,. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment:a prospective controlled trial. Am J Infect Control. 2013;41:1167–1172.
-
(2013)
Am J Infect Control
, vol.41
, pp. 1167-1172
-
-
Oren, I.1
Sprecher, H.2
Finkelstein, R.3
-
104
-
-
84879006895
-
Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit
-
T.Halaby, N.Al Naiemi, J.Kluytmans,. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57:3224–3229.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 3224-3229
-
-
Halaby, T.1
Al Naiemi, N.2
Kluytmans, J.3
-
105
-
-
84889080918
-
Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience
-
C.Lübbert, S.Faucheux, D.Becker-Rux,. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae:a single-centre experience. Int J Antimicrob Agents. 2013;42:565–570.
-
(2013)
Int J Antimicrob Agents
, vol.42
, pp. 565-570
-
-
Lübbert, C.1
Faucheux, S.2
Becker-Rux, D.3
-
106
-
-
78650262379
-
Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns
-
V.Strenger, T.Gschliesser, A.Grisold,. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns. Int J Antimicrob Agents. 2011;37:67–69.
-
(2011)
Int J Antimicrob Agents
, vol.37
, pp. 67-69
-
-
Strenger, V.1
Gschliesser, T.2
Grisold, A.3
-
107
-
-
80052434891
-
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state
-
T.Zuckerman, N.Benyamini, H.Sprecher,. SCT in patients with carbapenem resistant Klebsiella pneumoniae:a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant. 2011;46:1226–1230.
-
(2011)
Bone Marrow Transplant
, vol.46
, pp. 1226-1230
-
-
Zuckerman, T.1
Benyamini, N.2
Sprecher, H.3
-
108
-
-
84934325671
-
A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies
-
M.J.G.T.Vehreschild, A.Hamprecht, L.Peterson,. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother. 2014;69:3387–3392.
-
(2014)
J Antimicrob Chemother
, vol.69
, pp. 3387-3392
-
-
Vehreschild, M.J.G.T.1
Hamprecht, A.2
Peterson, L.3
-
109
-
-
84949084903
-
Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies
-
P.Cornejo-Juárez, J.A.Suárez-Cuenca, P.Volkow-Fernández,. Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies. Support Care Cancer. 2016;24:253–259.
-
(2016)
Support Care Cancer
, vol.24
, pp. 253-259
-
-
Cornejo-Juárez, P.1
Suárez-Cuenca, J.A.2
Volkow-Fernández, P.3
-
110
-
-
84923228267
-
Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation
-
L.Nesher, K.V.I.Rolston, D.P.Shah,. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2015;17:33–38.
-
(2015)
Transpl Infect Dis
, vol.17
, pp. 33-38
-
-
Nesher, L.1
Rolston, K.V.I.2
Shah, D.P.3
-
111
-
-
84942084780
-
Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing
-
R.Banerjee, C.B.Teng, S.A.Cunningham,. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clin Infect Dis. 2015;61:1071–1080.
-
(2015)
Clin Infect Dis
, vol.61
, pp. 1071-1080
-
-
Banerjee, R.1
Teng, C.B.2
Cunningham, S.A.3
|